Tomas Pachano

Tomas Pachano

Auto-generated profile, based on publicly available information

Tomas Pachano

Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TPTomas Pachano
Tomas Pachano
VSVíctor Sánchez-Gaya
Víctor Sánchez-Gaya
TEThais Ealo
Thais Ealo
MMMaria Mariner-Faulí
Maria Mariner-Faulí
TBTore Bleckwehl
Tore Bleckwehl
ARAlvaro Rada-Iglesias
Alvaro Rada-Iglesias

16 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
GCGiuliano Crispatzu
Giuliano Crispatzu
RRRizwan Rehimi
Rizwan Rehimi
TPTomas Pachano
Tomas Pachano
TBTore Bleckwehl
Tore Bleckwehl
SCSara Cruz-Molina
Sara Cruz-Molina
ARAlvaro Rada-Iglesias
Alvaro Rada-Iglesias
Poised enhancers (PEs) represent a genetically distinct set of distal regulatory elements that control the expression of major developmental genes. Before becoming activated in differentiating cells, PEs are already bookmarked in pluripotent cells with unique chromatin and topological features that could contribute to their privileged regulatory properties. However, since PEs were originally characterized in embryonic stem cells (ESC), it is currently unknown whether PEs are functionally conserved in vivo. Here, we show that the chromatin and 3D structural features of PEs are conserved among mouse pluripotent cells both in vitro and in vivo. We also uncovered that the interactions between PEs and their target genes are globally controlled by the combined action of Polycomb, Trithorax and architectural proteins. Moreover, distal regulatory sequences located close to developmental genes and displaying the typical genetic (i.e. CpG islands) and chromatin (i.e. high accessibility and H3K27me3 levels) features of PEs are commonly found across vertebrates. These putative PEs show high sequence conservation within specific vertebrate clades, with only a few being evolutionary conserved across all vertebrates. Lastly, by genetically disrupting PEs in mouse and chicken embryos, we demonstrate that these regulatory elements play essential roles during the induction of major developmental genes in vivo.

10 June 2022 in Development
Verified
Journal Article
Open access
PDF file
TPTomás Pachano
Tomás Pachano
EHEndika Haro
Endika Haro
ARAlvaro Rada-Iglesias
Alvaro Rada-Iglesias
Enhancers control the establishment of spatiotemporal gene expression patterns throughout development. Over the past decade, the development of new technologies has improved our capacity to link enhancers with their target genes based on their colocalization within the same topological domains. However, the mechanisms that regulate how enhancers specifically activate some genes but not others within a given domain remain unclear. In this Review, we discuss recent insights into the factors controlling enhancer specificity, including the genetic composition of enhancers and promoters, the linear and 3D distance between enhancers and their target genes, and cell-type specific chromatin landscapes. We also discuss how elucidating the molecular principles of enhancer specificity might help us to better understand and predict the pathological consequences of human genetic, epigenetic and structural variants.

17 November 2025 in bioRxiv
Verified
Preprint
Open access
TPTomas Pachano
Tomas Pachano
HLHe Leng
He Leng
GDGuillaume Dugied
Guillaume Dugied
TTTravis Tribble
Travis Tribble
VLVincent Loubiere
Vincent Loubiere
MTMikko Taipale
Mikko Taipale
SUMMARY: Pathogens deploy effector proteins to exploit host cell biology, and most pathogen open reading frames (ORFs) are rapidly evolving and lack functional annotation. We developed the eORFeome, a scalable functional genomics platform encompassing 3,835 effector ORFs from diverse viruses, bacteria, and parasites. High-throughput barcoded screens across NFκB, apoptosis, p53, cGAS–STING and MHC-I pathways revealed functions for hundreds of uncharacterized eORFs, unexpected new activities for known effectors, and distinct pathway-specific functions encoded by single ORFs. Illustrating the power of the approach, we identify HHV6A U14 as a p53 antagonist, HHV7 U21 as a dual-function STING antagonist and MHC-I antigen display inhibitor, and adenoviral 13.6K/i-leader protein as a de novo evolved TAP inhibitor that suppresses MHC-I display. These results establish a general framework for systematic effector annotation, uncover new mechanisms of host–pathogen interaction across kingdoms, and highlight pathogen effectors as a versatile toolkit for rewiring and probing human cellular pathways.

8 August 2025 in bioRxiv
Verified
Preprint
Open access
EHEndika Haro
Endika Haro
MIMarianna Iliadou
Marianna Iliadou
SRShyam Ramasamy
Shyam Ramasamy
TEThais Ealo
Thais Ealo
VCVictor M. Campa
Victor M. Campa
ARAlvaro Rada-Iglesias
Alvaro Rada-Iglesias
Enhancers are non-coding cis -regulatory elements that control the expression of distally located genes in a tissue- and time-specific manner. Recent studies indicate that enhancers can differ in their underlying genetic architecture and regulatory properties. However, these different types of enhancers were previously investigated under rather variable conditions (e.g. model organism, cell type, enhancer-promoter distance, type of target promoter, etc .), thus introducing confounding factors that make it difficult to discern the distinct regulatory properties of each enhancer type. To overcome these limitations, here we generated transgenic mouse embryonic stem cells (mESC) lines in which different types of synthetic enhancers (i.e. “typical” enhancer, CTCF-associated enhancer, enhancer cluster/super-enhancer) were built upon the same “core” neural enhancer and inserted at the same distance (i.e. 100 Kb) from a typical developmental gene (i.e. Gata6 ). Subsequently, the mESC lines were differentiated to systematically compare the regulatory properties of the different enhancer types under identical conditions. Regarding the CTCF-associated enhancer, our data revealed that the addition of a CTCF site to the “core” enhancer increased insulation and led to the formation of a smaller contact domain, while having a rather mild effect on enhancer-promoter contact frequency and target gene expression. On the other hand, in comparison to the “core” enhancer alone, the enhancer cluster synergistically increased target gene expression and burst fraction. Importantly, we found that, in contrast to previous models, the strong regulatory activity of the enhancer cluster can not be explained by changes in enhancer-promoter contact frequency or the formation of transcriptional condensates. Instead, our data suggest that the emergent regulatory properties of enhancer clustering preferentially entail an increase in RNA Polymerase II pause release and, thus, in the fraction of enhancer-promoter contacts that are transcriptionally productive.